Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Prognostic value of circulating tumor DNA following local therapy in colorectal cancer with liver metastases.
Authors
Conor O'Donnell
Mayo Clinic School of Graduate Medical Education, Rochester, MN
Conor O'Donnell , Michael H. Storandt , Jessica L. Mitchell , Zhaohui Jin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Diagnostics
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 26)
DOI
10.1200/JCO.2024.42.3_suppl.26
Abstract #
26
Poster Bd #
C7
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Breakthrough
Systemic treatment post curative-intent intervention based on tumor-informed circulating tumor DNA result for oligometastatic colorectal cancer.
First Author: Teerada Siripoon
Poster
2017 Gastrointestinal Cancers Symposium
Sequencing cell free DNA in patients receiving selective internal radiation therapy for colorectal liver metastases.
First Author: Helen Winter
Poster
2014 ASCO Annual Meeting
Molecular evaluation of primary tumor (PT) and synchronous liver metastasis in colorectal cancer (srLmCRC) patients after cetuximab-based chemotherapy.
First Author: Daniela Adua
Poster
2024 ASCO Gastrointestinal Cancers Symposium
A decade of chemotherapy management in hepatocellular carcinoma: A single-center study in Latin America.
First Author: Wagner Eduardo Cruz Diaz